Doug Kerr, an officer of Dyne Therapeutics, proposes to sell 5000 common shares valued at $121745.00. The planned transaction matters to investors because it identifies a proposed insider sale, while the record also lists restricted-stock-unit issuances and earlier common-stock transactions involving Kerr.

Key Highlights

  • The record lists 11,875 common shares through restricted stock units dated 09/03/2026.
  • The record lists 3000 common shares through restricted stock units dated 09/04/2026.
  • Earlier listed transactions involved 887 shares for $16,263 and 1556 shares for $40,892.

Dyne Therapeutics, Inc. (NASDAQ: DYN) officer Doug Kerr proposed selling common stock listed at $121,745 on 09/04/2026. The proposed transaction covers 5000 common shares and identifies Stifel Nicolaus & Company Inc as the broker.

5000-Share Sale Kerr

The record lists 186,746,431 shares outstanding and identifies Nasdaq as the market for the common stock. James Weimer signed for Stifel Nicolaus & Company Inc as attorney-in-fact for Kerr. The broker’s address is 501 N Broadway, St. Louis, MO 63,102. The same record lists restricted-stock-unit activity involving Kerr. The filing shows 11,875 common shares dated 09/03/2026 and 3000 common shares dated 09/04/2026, each connected with issuer Equity compensation.

Kerr’s Earlier Stock Transactions Kerr’s

listed common-stock transactions include 887 shares dated 06/16/2026 with a stated amount of $16,263. Another entry records 1556 shares dated 08/13/2026 with a stated amount of $40,892.